Osmetech Share Discussion Threads

[malc5] 22/3/2010 13:21

I'm sticking around, as I said before all the insti's give me confidence and someone is mopping up here IMO.

[roobarb36] 22/3/2010 12:15

whilest2

Just do a dummy online purchase as I did this morning for 50,000 shares on a T3.
I was quoted 1.851 pence to buy.

There will be a few buys and a few sells with all the uncertainty but would be very surprised if the 3 million and 2 million trades on Friday were sells as they were at approx 1.88 pence. Given that these trades represent £57,000 and £40,000 respectively it shows a certain degree of confidence from somebody.

The other thing you have to bear in mind was the massive surge in buying over a 2 day period at the beginning of January without any relevant news when if I remember correctly about 45 million shares were bought in one day alone at or around the 2.05p mark. That days total equated to round about a milion pounds, admittedly this included P.I's but there were numerous 6 million and 8 million trades which does get you thinking.

[whilest2] 22/3/2010 11:49

Happy days honesty. Despite the small scramble for the door the bid stays up.
We will see when the US gamblers get in. I am staying for the ride

[whilest2] 22/3/2010 11:25

More than a good story - an accurate well balanced account of all the risks and problems with this company and the highly competitive field it is in.Certainly where the US issue is concerned a gambling share. But imho it will be priced around $2.50-3.00

[qackers] 21/3/2010 22:17

They do tell a good story. If only they delivered.

[qackers] 21/3/2010 21:55

For the record. No price etc etc.

PASADENA, Calif. - (Business Wire) GenMark Diagnostics, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. GenMark is a Delaware corporation and, in connection with the offering, will become the parent holding company of Osmetech, plc.
Piper Jaffray & Co. will act as the sole book-running manager, and Leerink Swann LLC will act as the co-manager for the proposed offering. The number of shares to be offered and the price range of the proposed offering have not yet been determined. All of the shares of common stock will be offered by GenMark.

The proposed offering will be made only by means of a prospectus. Once available, a preliminary prospectus relating to the proposed offering may be obtained from Piper Jaffray & Co. at 800 Nicollet Mall, Suite 800, Minneapolis, MN 55402 or by calling [phone].

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy these securities be accepted prior to the time that the registration statement becomes effective. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The prospectus related to the proposed offering will be included in the registration statement.

About GenMark and Osmetech

GenMark is the planned Delaware parent company of Osmetech, plc, a corporation registered in England and Wales. We are a molecular diagnostics company focused on developing and commercializing our proprietary eSensor® detection technology. Our XT-8 System enables multiplex detection of DNA and RNA targets. We are commercializing two FDA-cleared diagnostic tests for use with our XT-8 System, a Cystic Fibrosis Genotyping Test and a Warfarin Sensitivity Test. We are based in Pasadena, California.

Forward-Looking Statements

This news release contains forward-looking statements that are based on GenMark's and Osmetech's current beliefs and assumptions and on information currently available to their management. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of GenMark and Osmetech to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. As a result of these risks, uncertainties and other factors, readers are cautioned not to place undue reliance on any forward-looking statements included in this press release. These forward-looking statements represent beliefs and assumptions only as of the date of this news release, and neither GenMark nor Osmetech assume any obligation to update these forward-looking statements publicly, even if new information becomes available in the future.



GenMark Diagnostics, Inc.
Steven Kemper, Chief Financial Officer
[phone]



Read more:

[marvin9] 21/3/2010 20:22

Been to see me ole voodoo doctor today and put a bit of a bad luck spell on Sandrat and jimmy riddle. Cost me £30 but well worth it

[marvin9] 21/3/2010 20:16

As I posted over 4 years ago:

[marvin9] 21/3/2010 16:56

I agree jerry, yet another ramper ;)

[marvin9] 21/3/2010 16:54

Not sure why your all moaning, according to the directors reports we can all expect exciting times ahead and Mr Sandiland has do a suppurb job in getting us where we are at today.

LOL only in the osmo world.

Nothing but a scam since day one.

So whilest how much have you lost on this one?

[whilest2] 21/3/2010 13:42

They have to go to $4 just to keep parity with the today prices of omh.

[gerry2] 21/3/2010 13:17

As much as that?

[hoggar] 21/3/2010 10:23

Anyone remembered my prediction stated 3 jan 2010, post 4617 on the other thread. 'This company is ready for de-listing'.

The next prediction = They will get short change on an American listing due to poor performance and prospects. This company will eventually end up in oblivion and might fetch $1.00

[hoggar] 21/3/2010 10:21

Anyone remembered my prediction stated 3 jan 2010, post 4617. 'This company is ready for de-listing'.

The next prediction = They will get short change on an American listing due to poor performance and prospects. This company will eventually end up in oblivion and might fetch $1.00

[sequoia] 20/3/2010 18:21

New shares need to be £4.50 ;-)
lol seq.

[sequoia] 20/3/2010 18:16

And how much will the new shares be worth 230 omh = 1 gentec looks like we are screwed again.
seq

[whilest2] 20/3/2010 14:40

Marvin good luk or RIP - you have entertained us all thru the hard times -
now the dawn?

[whilest2] 19/3/2010 21:47

That looks like a buying order mopping up the lot.
The test - what they open in the US after the launch.
I am staying for the champers......